The Misoprostol-Only Regimen Evidence Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

1,900

Participants

Timeline

Start Date

October 10, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Abortion, Medical
Interventions
DRUG

Misoprostol-only medication abortion regimen

This intervention is an updated misoprostol-only regimen that involves being counseled on and receiving medications for a medication abortion using 3-4 doses of 800μg misoprostol administered sublingually every 3 hours.

DRUG

Combined regimen

This intervention will involve participants being counseled on and receiving medications for a medication abortion regimen of mifepristone (200mg orally) followed 24-48 hours later by misoprostol (800μg b/v) with a second dose of misoprostol (800μg b/v) taken 3 hours later only for those 64-77 days.

Trial Locations (1)

84102

Planned Parenthood Association of Utah, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

University of Utah

OTHER

collaborator

Planned Parenthood Association of Utah

UNKNOWN

lead

Ibis Reproductive Health

OTHER